The ASCO Post Podcast

FDA Approval for Newly Diagnosed Acute Myeloid Leukemia


Listen Later

This week, we’re covering the FDA approval of a doublet therapy in certain populations of patients with newly diagnosed acute myeloid leukemia. Then we’ll hear about a comparison study of treatments for patients with metastatic breast cancer and brain metastases.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Ivosidenib/Azacitidine for Certain Patients With Newly Diagnosed AML

Etirinotecan Pegol vs Physician’s Choice of Chemotherapy for Patients With Metastatic Breast Cancer and Brain Metastases

To listen to more podcasts from ASCO, visit asco.org/podcasts.

...more
View all episodesView all episodes
Download on the App Store

The ASCO Post PodcastBy BroadcastMed

  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

15 ratings


More shows like The ASCO Post Podcast

View all
Research To Practice | Oncology Videos by Dr Neil Love

Research To Practice | Oncology Videos

116 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

58 Listeners